FDA’s new guidance on general wellness
This post critiques the widening regulatory gap between the US and EU following the FDA's new wellness guidance, highlighting how lower barriers for bold health claims in the US may sacrifice essential quality drivers and complicate global strategies for startups.
What can we learn from… Canada?
This post explores the "Canadian Technology Accelerator" model for international expansion, sharing insights from a bilingual FemTech panel in Paris on how high-potential startups - like PCOS-focused mentee Élan Healthcare - can leverage diplomatic networks and local mentorship to navigate global regulatory compliance.
